Blogs
Why Most “Low-Carb” Diets Fail During GLP-1 Therapy
Many GLP-1 patients attempt low-carb diets while using semaglutide or tirzepatide — yet still struggle with fatigue, plateaus, cravings, poor body composition, and stalled progress. This article explains why most “low-carb” approaches fail metabolically and how diet composition affects satiety, energy regulation, and long-term GLP-1 outcomes.
Read More
Why Ultra-Processed “High-Protein” Foods Fail GLP-1 Patients
Many GLP-1 patients increase protein intake but still struggle with fatigue, plateaus, hunger, muscle loss, or rebound weight gain. This article explains why ultra-processed “high-protein” foods often fail to support metabolic health, satiety, and long-term GLP-1 outcomes.
Read More
Your Body Already Has a GLP-1 System. Here's Why It's Not Working.
Ozempic didn't invent GLP-1. Your gut has been making it after every meal for your entire life. When it's working, you eat and don't think...
Read More
Why Lean Mass Preservation Should Be a Core GLP-1 Outcome
A provider-focused explanation of why preserving lean mass during GLP-1 therapy is critical for metabolic health, weight maintenance, and long-term treatment success.
Read More
Why Weight Regain Happens After Stopping GLP-1 Therapy
A provider-facing explanation of why patients often regain weight after stopping semaglutide or tirzepatide, including defended body weight, appetite rebound, metabolic lag, lean mass loss, and the importance of the transition phase.
Read More
Why Weight Loss Plateaus Occur During GLP-1 Therapy
A provider-facing explanation of why GLP-1 patients often hit plateaus, covering metabolic adaptation, reduced energy expenditure, lean mass loss, and the importance of framing plateaus as a normal treatment phase rather than medication failure.
Read More